A sensitive amperometric immunosensor for the detection of carcinoembryonic antigen using ZnMn2O4@reduced graphene oxide composites as signal amplifier

[Display omitted] •A sensitive amperometric immunosensor was designed and fabricated for detection of carcinoembryonic antigen.•ZnMn2O4@reduced graphene oxide composites were applied as signal amplifier to indicate the specific recognition.•The proposed immunosensor exhibited a wide detection range...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sensors and actuators. B, Chemical Chemical, 2021-07, Vol.339, p.129852, Article 129852
Hauptverfasser: Fan, Xinxia, Deng, Dongmei, Chen, Zichao, Qi, Ji, Li, Yuanyuan, Han, Baosan, Huan, Ke, Luo, Liqiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •A sensitive amperometric immunosensor was designed and fabricated for detection of carcinoembryonic antigen.•ZnMn2O4@reduced graphene oxide composites were applied as signal amplifier to indicate the specific recognition.•The proposed immunosensor exhibited a wide detection range with high selectivity and long-term stability.•The novel immunosensor offered an alternative approach for tumor markers in clinical diagnosis. A novel amperometric immunosensor was designed and fabricated to sensitively detect carcinoembryonic antigen (CEA) using ZnMn2O4@reduced graphene oxide (ZnMn2O4@rGO) composites as signal amplifier. In this designed sensing platform, ZnMn2O4@rGO composites were facilely synthesized via a simple solvothermal process. The morphology and structure characteristics of composites were explored through scanning electron microscope, X-ray powder diffraction and X-ray photoelectron spectroscopy. The construction process of the immunosensor was monitored by cyclic voltammetry and A.C. impedance. The remarkable change in the electrocatalytic current of ZnMn2O4@rGO to H2O2 indicated the immunoreaction between antibody and CEA, resulting in sensitive detection of CEA with a broad linear range from 0.01 to 50 ng/mL (R2 = 0.9988) and a low detection limit of 1.93 pg/mL. Moreover, real human serum sample analysis demonstrated the availability of the immunosensor to monitor CEA as well as other tumor markers in clinical diagnosis.
ISSN:0925-4005
1873-3077
DOI:10.1016/j.snb.2021.129852